Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 9
Submit an article Journal homepage
1,072
Views
48
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia

Alessandra TedeschiDepartment of Hematology, Niguarda Ca’ Granda Hospital, Milano, ItalyCorrespondence[email protected]
,
Paola PicardiDepartment of Hematology, Niguarda Ca’ Granda Hospital, Milano, Italy
,
Simone FerreroDepartment of Hematology, University of Torino, Torino, Italy
,
Giulia BenevoloDepartment of Hematology, AO Città della Salute e della Scienza di Torino, San Giovanni Battista, Torino, Italy
,
Gloria Margiotta CasaluciDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
,
Marzia VarettoniDepartment of Hematology, IRCCS Policlinico San Matteo, Pavia, Italy
,
Claudia BaratèDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
,
Marina MottaDepartment of Hematology, AO Spedali Civili, Brescia, Italy
,
Guido GiniDepartment of Hematology, AOU Ospedali Riuniti, Ancona, Italy
,
Maria Cecilia GoldanigaDepartment of Hematology, IRCCS Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy
,
Carlo ViscoDepartment of Cell Therapy and Hematology, Ospedale San Bortolo, Vicenza, Italy
,
Francesco ZajaDepartment of Hematology, AO Universitaria S. Maria Misericordia, Udine, Italy
,
Valeria Belsito PetriziDepartment of Oncology and Hematology, General Hospital, Nocera Inferiore, Italy
,
Erika RavelliDepartment of Internal Medicine, Valduce Hospital, Como, Italy
,
Massimo GentileDepartment of Hematology, AO di Cosenza, Cosenza, Italy
,
Marina Aurora UrbanoDepartment of Hematology, University of Torino, Torino, Italy
,
Silvia FranceschettiDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
,
Paola GhioneDepartment of Hematology, University of Torino, Torino, Italy
,
Lorella OrsucciDepartment of Hematology, AO Città della Salute e della Scienza di Torino, San Giovanni Battista, Torino, Italy
,
Anna Maria FrustaciDepartment of Hematology, Niguarda Ca’ Granda Hospital, Milano, Italy
,
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
,
Umberto VitoloDepartment of Hematology, AO Città della Salute e della Scienza di Torino, San Giovanni Battista, Torino, Italy
&
Enrica MorraDepartment of Hematology, Niguarda Ca’ Granda Hospital, Milano, Italy
 show all
Pages 2637-2642 | Received 31 Oct 2014, Accepted 21 Jan 2015, Published online: 14 Mar 2015

Citations (48)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Karima Amaador, Marie J. Kersten, Monique C. Minnema & Josephine M. I. Vos. (2023) Treatment of relapsed and refractory Waldenstrom Macroglobulinemia. Leukemia & Lymphoma 64:1, pages 30-41.
Read now
Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou & Meletios Athanasios Dimopoulos. (2021) Ibrutinib plus rituximab for the treatment of adult patients with Waldenström’s macroglobulinemia: a safety evaluation. Expert Opinion on Drug Safety 20:9, pages 987-995.
Read now
Shayna Sarosiek, Steven P. Treon & Jorge J. Castillo. (2021) Reducing treatment toxicity in Waldenström macroglobulinemia. Expert Opinion on Drug Safety 20:6, pages 669-676.
Read now
Ana Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo, Katya Sosa, Nathalie Josseaume, Circe Mesa, Kalet León, Tays Hernández & Jean-Luc Teillaud. (2020) A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy. OncoImmunology 9:1.
Read now
Yan-Hua Zheng, Li Xu, Chun Cao, Juan Feng, Hai-Long Tang, Mi-Mi Shu, Guang-Xun Gao & Xie-Qun Chen. (2019) Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis. OncoTargets and Therapy 12, pages 2751-2766.
Read now
Jithma P Abeykoon, Uday Yanamandra & Prashant Kapoor. (2017) New developments in the management of Waldenström macroglobulinemia. Cancer Management and Research 9, pages 73-83.
Read now
Giulia Benevolo, Maura Nicolosi, Elisa Santambrogio & Umberto Vitolo. (2017) Current options to manage Waldenström’s macroglobulinemia. Expert Review of Hematology 10:7, pages 637-647.
Read now
David A. Bond, Ying Huang, Amy S. Ruppert, Alison R. Walker, Emily K. Dotson, Julianna Roddy, Kristie A. Blum & Beth A. Christian. (2017) Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose. Leukemia & Lymphoma 58:7, pages 1589-1597.
Read now
Andrea Aiello, Anna D’Ausilio, Roberta Lo Muto, Francesca Randon & Luca Laurenti. (2017) Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy. Journal of Market Access & Health Policy 5:1.
Read now
Rajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell & Morie A Gertz. (2015) Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. Expert Review of Anticancer Therapy 15:10, pages 1143-1156.
Read now
Christian Buske & J. F. Seymour. (2015) Immunochemotherapy in Waldenström macroglobulinemia – still the backbone of treatment. Leukemia & Lymphoma 56:9, pages 2489-2490.
Read now

Articles from other publishers (37)

Ramón García-Sanz & Alessandra Tedeschi. (2023) The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia. Hematology/Oncology Clinics of North America 37:4, pages 727-749.
Crossref
Prashant Kapoor, Jonas Paludo & Jithma P. Abeykoon. (2023) Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy. Hematology/Oncology Clinics of North America 37:4, pages 671-687.
Crossref
Bushra Ghafoor, Shameera Shaik Masthan, Maha Hameed, Hafiza Huda Akhtar, Azeem Khalid, Sana Ghafoor, Hassan min Allah, Mohammad Mohsin Arshad, Iman Iqbal, Ahmad Iftikhar, Muhammad Husnain & Faiz Anwer. (2023) Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects. Annals of Hematology.
Crossref
Suzanne O. Arulogun, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, RayMun Koo, Aideen T. O'Neill, Josephine M. I. Vos, Guy Pratt, Deborah Turner, Kirsty Marshall, Kate Manos, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, Marie J. Kersten, Monique C. Minnema, Eirini Koutoumanou, Dima El‐Sharkawi, Kim Linton, Dipti Talaulikar, Helen McCarthy, Mark Bishton, George Follows, Ashutosh Wechalekar & Shirley P. D'Sa. (2023) Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing. American Journal of Hematology 98:5, pages 750-759.
Crossref
Morie A. Gertz. (2023) Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. American Journal of Hematology 98:2, pages 348-358.
Crossref
Shayna Sarosiek, Andrew R. Branagan, Steven P. Treon & Jorge J. Castillo. (2022) IgM-Related Immunoglobulin Light Chain (AL) Amyloidosis. Hemato 3:4, pages 731-741.
Crossref
Zdeněk Adam, David Zeman, Luděk Pour, Marta Krejčí, Martin Krejčí, Zdeněk Řehák, Renata Koukalová, Viera Sandecká, Martin Štork, Gabriela Romanová, Zuzana Adamová & Zdeněk Král. (2022) Waldenström´s macroglobulinemia, overview of clinical symptoms, and therapy and our experience with ibrutinib therapy. Onkologie 16:Suppl. B, pages 83-102.
Crossref
Rayan Kaedbey, Nicholas Forward, Laurie H. Sehn, Mona Shafey, Sarah Doucette & Christine I. Chen. (2022) A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia. Current Oncology 29:10, pages 7122-7139.
Crossref
Morie A. Gertz. (2022) Waldenstrom Macroglobulinemia: Tailoring Therapy for the Individual. Journal of Clinical Oncology 40:23, pages 2600-2608.
Crossref
Julien Labreuche, Deborah Assouan, Eric Durot, Cecile Tomowiak, Damien Roos‐Weil, Elise Toussaint, Fontanet Bijou, Richard Lemal, Annie Brion, Kamel Laribi, Loic Ysebaert, Alain Duhamel & Pierre Morel. (2022) Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia?. Hematological Oncology 40:3, pages 400-408.
Crossref
Guy Pratt, Dima El‐Sharkawi, Jaimal Kothari, Shirley D’Sa, Rebecca Auer, Helen McCarthy, Rajesh Krishna, Oliver Miles, Charalampia Kyriakou & Roger Owen. (2022) Diagnosis and management of Waldenström macroglobulinaemia—A British Society for Haematology guideline . British Journal of Haematology 197:2, pages 171-187.
Crossref
Yosuke Masamoto, Arika Shimura & Mineo Kurokawa. (2021) Reduced bendamustine for elderly patients with follicular lymphoma. Annals of Hematology 101:3, pages 713-715.
Crossref
Saurabh Zanwar & Jithma P. Abeykoon. (2022) Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond. Therapeutic Advances in Hematology 13, pages 204062072210939.
Crossref
Shayna Sarosiek, Steven P. Treon & Jorge J. Castillo. (2021) How to Sequence Therapies in Waldenström Macroglobulinemia. Current Treatment Options in Oncology 22:10.
Crossref
Morie A. Gertz. (2021) Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management. American Journal of Hematology 96:2, pages 258-269.
Crossref
Frederic Larose & Christine I Chen. (2021) Bruton's Tyrosine Kinase Inhibitors for the Treatment of Waldenström's Macroglobulinaemia: A Canadian Perspective. Oncology & Haematology 17:2, pages 73.
Crossref
Christopher N. Grimont, Natalia E. Castillo Almeida & Morie A. Gertz. (2021) Current and Emerging Treatments for Waldenström Macroglobulinemia. Acta Haematologica 144:2, pages 146-157.
Crossref
Shahrzad Jalali, Jie Shi, Alex Buko, Nagib Ahsan, Jonas Paludo, Makayla Serres, Linda E. Wellik, Jithma Abeykoon, HyoJin Kim, Xinyi Tang, Zhi-Zhang Yang, Anne J. Novak, Thomas E. Witzig & Stephen M. Ansell. (2020) Increased glutathione utilization augments tumor cell proliferation in Waldenstrom Macroglobulinemia. Redox Biology 36, pages 101657.
Crossref
F. Massa, A. Zuppa, G. Pesce, C. Demichelis, M. Bergamaschi, M. Garnero, C. Briani, S. Ferrari, A. Schenone & L. Benedetti. (2020) Bendamustine–rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. Journal of the Neurological Sciences 413, pages 116777.
Crossref
Saurabh Zanwar, Jithma Prasad Abeykoon & Prashant Kapoor. (2020) Novel Treatment Strategies in the Management of Waldenström Macroglobulinemia. Current Hematologic Malignancy Reports 15:1, pages 31-43.
Crossref
Shayna Sarosiek & Jorge J. Castillo. 2020. Novel Therapeutics for Rare Lymphomas. Novel Therapeutics for Rare Lymphomas 15 26 .
Meletios A. Dimopoulos & Efstathios Kastritis. (2019) How I treat Waldenström macroglobulinemia. Blood 134:23, pages 2022-2035.
Crossref
Pooja Advani, Aneel Paulus & Sikander Ailawadhi. (2019) Updates in prognostication and treatment of Waldenström’s macroglobulinemia. Hematology/Oncology and Stem Cell Therapy 12:4, pages 179-188.
Crossref
Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Ronan Le Calloch, Jean R. Eveillard, Charles Herbaux, Damien Roos‐Weil, Driss Chaoui, Xavier Roussel, Sabine Tricot, Jehan Dupuis, Caroline Dartigeas, Benoit Bareau, Marie C. Bene, Alix Baugier de Materre & Véronique Leblond. (2018) Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO). British Journal of Haematology 186:1, pages 146-149.
Crossref
Pooja Advani, Aneel Paulus & Sikander Ailawadhi. (2019) WITHDRAWN: Updates in Prognostication and Treatment of Waldenström’s Macroglobulinemia. Hematology/Oncology and Stem Cell Therapy.
Crossref
Alessandra Tedeschi, Concetta Conticello, Rita Rizzi, Giulia Benevolo, Luca Laurenti, Maria Teresa Petrucci, Francesco Zaja & Marzia Varettoni. (2018) Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia. Hematological Oncology 37:2, pages 117-128.
Crossref
Morie A. Gertz. (2018) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology 94:2, pages 266-276.
Crossref
Saurabh Zanwar, Jithma Prasad Abeykoon & Prashant Kapoor. (2019) Current Therapeutic Options in Waldenström Macroglobulinemia. Oncology & Hematology Review (US) 15:1, pages 39.
Crossref
Na Li, Michael A. Lopez, Maria Linares, Subodh Kumar, Stefania Oliva, Joaquin Martinez-Lopez, Lian Xu, Yan Xu, Tommaso Perini, William Senapedis, Erkan Baloglu, Masood A. Shammas, Zachary Hunter, Kenneth C. Anderson, Steven P. Treon, Nikhil C. Munshi & Mariateresa Fulciniti. (2019) Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia. Clinical Cancer Research 25:1, pages 369-377.
Crossref
Jonas Paludo, Jithma P. Abeykoon, Amanda Shreders, Stephen M. Ansell, Shaji Kumar, Sikander Ailawadhi, Rebecca L. King, Amber B. Koehler, Craig B. Reeder, Francis K. Buadi, Angela Dispenzieri, Martha Q. Lacy, David Dingli, Thomas E. Witzig, Ronald S. Go, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Nelson Leung, Thomas M. Habermann, Suzanne Hayman, Yi Lin, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz & Prashant Kapoor. (2018) Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia. Annals of Hematology 97:8, pages 1417-1425.
Crossref
Laurence Simon, Marine Baron & Véronique Leblond. (2018) How we manage patients with Waldenström macroglobulinaemia. British Journal of Haematology 181:6, pages 737-751.
Crossref
Morie A. Gertz. (2018) Waldenström macroglobulinemia treatment algorithm 2018. Blood Cancer Journal 8:4.
Crossref
David Ribes, Hélène E. L. Hachem, Lucie Oberic, François Vergez, Audrey Delas, Julie Belliere, Caroline Protin, Nassim Kamar, Inès Ferrandiz, Suzanne Tavitian, Camille Laurent, Antoine Huart, Dominique Chauveau, Loïc Ysebaert & Stanislas Faguer. (2018) Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance. American Journal of Hematology 93:3, pages 356-362.
Crossref
Morie A. Gertz. (2017) Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. American Journal of Hematology 92:2, pages 209-217.
Crossref
Véronique Leblond, Laetitia Souchet, Sylvain Choquet & Christian Buske. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia 315 326 .
Véronique LeblondEfstathios KastritisRanjana AdvaniStephen M. AnsellChristian BuskeJorge J. CastilloRamón García-SanzMorie GertzEva KimbyCharalampia KyriakouGiampaolo MerliniMonique C. MinnemaPierre MorelEnrica MorraMathias Rummel, Ashutosh Wechalekar, Christopher J. PattersonSteven P. TreonMeletios A. Dimopoulos. (2016) Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia. Blood 128:10, pages 1321-1328.
Crossref
Efstathios Kastritis & Meletios A. Dimopoulos. (2016) Current therapy guidelines for Waldenstrom's macroglobulinaemia. Best Practice & Research Clinical Haematology 29:2, pages 194-205.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.